- Some 3,000 people joined the trial last weekend, after approval by the Brazilian Health Regulatory Agency (Anvisa).
- The initiative thus makes Brazil the first country to start human trials outside the United Kingdom.
- Brazil is one of the hardest hit in the world by the new coronavirus pandemic, coming second after the United States.
A vaccine against the new coronavirus, which is being developed by the University of Oxford, in the United Kingdom, has started human trials in Brazil, the country with the second-highest number of cases and deaths from the coronavirus pandemic. The tests began in São Paulo and Rio de Janeiro.
Some 3,000 people joined the trial last weekend, after approval by the Brazilian Health Regulatory Agency (Anvisa), responsible for monitoring tests and medicines. The initiative is led by the Reference Center for Special Immunobiologicals (CRIE), of the Federal University of São Paulo (Unifesp). It has financial support from the Lemann Foundation, maintained and created by Brazilian billionaire Jorge Paulo Lemann .
In a statement, the Lemann Foundation celebrated the start of the Oxford vaccine testing in Brazil, although it warned that the results will not be immediate. Brazil’s Interim health minister, Eduardo Pazuello, hinted at the possibility of the signing of a deal soon. He added that the nation is equally keen on forging other partnerships with other vaccine developers in a bid to defeat the coronavirus pandemic.
The initiative thus makes Brazil the first country to start human trials outside the United Kingdom to test immunization against COVID-19. The results of the tests, according to Unifesp, will be essential for the registration of the vaccine in the United Kingdom, scheduled for the end of this year, and which will depend on the completion of the studies carried out in all participating countries.
Brazil is one of the hardest hit in the world by the new coronavirus pandemic, coming second after the United States. It has so far registered more than 51,000 deaths due to the pandemic, and more than 1.1 million cases of infection. The World Health Organization (WHO) warned this week that the number of infected people may be higher, since, according to the organization, the country carried out few tests to find out how many people had been infected by the virus all over the country.
The COVID-19 pandemic has so far caused more than 472,000 deaths and infected more than 9.1 million people in 196 countries and territories worldwide as per a report prepared by the French news agency, AFP. The disease is transmitted by a new coronavirus detected in late December last year in Wuhan, a city in central China.
After Europe succeeded China as the center of the pandemic in February, the American continent is now the one with the most confirmed cases and the most deaths.
As per information courtesy of the WHO, Most people infected with the COVID-19 virus normally experience mild to moderate respiratory complications, and recover without needing any special treatment. The elderly people and those suffering from health complications, such as cardiovascular disease, chronic respiratory issues, diabetes, and cancer are the ones who are more likely to develop serious complications.
The best way to stay safe from the deadly pandemic is by observing high standards of hygiene, washing hands regularly, and avoiding touching your face with unclean hands. The COVID-19 virus mostly spreads via droplets of saliva or discharge from the nose of a victim of the disease when they cough or sneeze so it’s crucial to wear masks to minimize the chances of contracting the viral disease.